patients with stage ii disease of the pyriform sinus and stage ii and iv disease of the oral cavity , larynx , hypopharynx , oropharynx , nasopharynx , and paranasal sinuses were eligible .
C0227170
pyriform sinus
C0020629
hypopharynx